We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

New Solution on the Horizon for Mitral Valve Regurgitation

By HospiMedica International staff writers
Posted on 06 Jul 2016
Print article
Image: The Amend mitral valve repair annuloplasty ring (Photo courtesy of Valcare Medical).
Image: The Amend mitral valve repair annuloplasty ring (Photo courtesy of Valcare Medical).
A new semi-rigid annuloplasty ring provides an advanced, catheter-based solution for treating mitral valve regurgitation.

The Valcare Medical (Herzliya Pituach, Israel) Amend Mitral Valve Repair annuloplasty ring is a 'D' shaped device designed to repair the mitral valve and thereby reduce valvular incompetence. The device is delivered via a sub-xiphoid transapical approach with the aid of a delivery catheter inserted through the chest and into the heart under ¬fluoroscopic and echo guidance. The D-shaped ring is then deployed and positioned to match the annulus of the original valve.

A special mechanism provides control for moving and shaping the ring by modifying its geometry. Using a series of remotely activated mechanisms, the complete ring shape is achieved and a series of anchors in four different zones that are independently deployed attach the ring into the annulus. During the implantation procedure, the septal lateral dimension is reduced to achieve better lea¬flet coaptation, thereby reducing or eliminating the mitral regurgitation.

“Valcare's novel technology is a pioneering breakthrough for the treatment of mitral valve regurgitation, and could be a base for additional modalities for treatment of other valve disorders,” said Uri Geiger, chairman of the board Valcare. “The team is currently focusing on adapting the delivery technique to a transeptal approach allowing for deployment of the system through a puncture in the groin, as well as using the system to treat tricuspid incompetence, another extremely common problem.”

Mitral regurgitation (MR), the most common form of valvular heart disease, is a disorder of the heart in which the mitral valve does not close properly, causing regurgitation of blood from the left ventricle through the mitral valve and back into the left atrium. Patients with MR face a dilemma of whether to undergo corrective surgery early, when they might have no or few symptoms, or wait until their condition worsens, triggering the decision to proceed with surgery.

Related Links:
Valcare Medical

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mobile Digital Baby Scale
seca 334

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.